BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis-Reference-Cited by-同舟云学术

BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis

Published:2018-01 Issue:1 Volume:13 Page:73-84
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Bucciarelli Peter R.,Tan Kay See,Chudgar Neel P.,Brandt Whitney,Montecalvo Joseph,Eguchi Takashi,Liu Yuan,Aly Rania,Travis William D.,Adusumilli Prasad S.,Jones David R.

Funder

National Institutes of Health/National Cancer Institute

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference52 articles.

1. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer;Koo;Lung Cancer,2011

2. Patient satisfaction with postmastectomy breast reconstruction: a comparison of saline and silicone implants;McCarthy;Cancer,2010

3. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival;Fujimoto;J Thorac Cardiovasc Surg,2006

4. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer;Varlotto;Cancer,2009

5. Risk of recurrence in surgically resected stage I adenocarcinoma of the lung: Histopathologic and immunohistochemical analysis;Cho;Lung,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway;Translational Oncology;2024-03

2. Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier;Translational Lung Cancer Research;2023-10

3. Metastasis suppressor genes in clinical practice: are they druggable?;Cancer and Metastasis Reviews;2023-09-25

4. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics;Cancer and Metastasis Reviews;2023-06-28

5. Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma;Journal for ImmunoTherapy of Cancer;2023-06